Table 3.
Baseline characteristics of the patients in different risk groups.
| Characteristics | TCGA cohort | ICGC cohort | ||||
|---|---|---|---|---|---|---|
| High risk | Low risk | P value | High risk | Low risk | P value | |
| Age | 0.8604 | 0.0223 | ||||
| <65 | 103 | 102 | 55 | 27 | ||
| ≥65 | 68 | 70 | 120 | 29 | ||
| Gender | <0.0001 | 0.4411 | ||||
| Female | 52 | 58 | 44 | 17 | ||
| Male | 119 | 114 | 131 | 39 | ||
| Vital status | <0.0001 | 0.0960 | ||||
| Alive | 92 | 128 | 139 | 50 | ||
| Dead | 79 | 44 | 36 | 6 | ||
| Grade | 0.0152* | |||||
| I/II | 95 | 119 | ||||
| III/IV | 74 | 50 | ||||
| Unknown | 2 | 3 | ||||
| Stage | 0.1273 | 0.3749 | ||||
| I/II | 110 | 128 | 104 | 37 | ||
| III/IV | 48 | 35 | 71 | 19 | ||
| Unknown | 13 | 9 | 0 | 0 | ||
| T stage | 0.0402* | |||||
| T1/T2 | 120 | 132 | ||||
| T3/T4 | 51 | 37 | ||||
| Unknown | 0 | 3 | ||||
| M stage | 0.8220* | |||||
| M0 | 124 | 121 | ||||
| M1 | 1 | 2 | ||||
| Unknown | 46 | 49 | ||||
| N stage | 1.0000* | |||||
| N0 | 119 | 120 | ||||
| N1 | 2 | 1 | ||||
| Unknown | 50 | 51 | ||||
*Fisher’s test.